c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
The c-Myc oncoprotein is a transcription factor which is a critical regulator of cellular proliferation. Deregulated expression of c-Myc is associated with many human cancers, including Burkitt's lymphoma. The c-Myc protein is normally degraded very rapidly with a half-life of 20 to 30 min. Here we demonstrate that proteolysis of c-Myc in vivo is mediated by the ubiquitin-proteasome pathway. Inhibition of proteasome activity blocks c-Myc degradation, and c-Myc is a substrate for ubiquitination in vivo. Furthermore, an increase in c-Myc stability occurs in mitotic cells and is associated with inhibited c-Myc ubiquitination. Deletion analysis was used to identify regions of the c-Myc protein which are required for rapid proteolysis. We found that a centrally located PEST sequence, amino acids 226 to 270, is necessary for rapid c-Myc degradation, but not for ubiquitination. Also, N-terminal sequences, located within the first 158 amino acids of c-Myc, are necessary for both efficient c-Myc ubiquitination and subsequent degradation. We found that c-Myc is significantly stabilized (two- to sixfold) in many Burkitt's lymphoma-derived cell lines, suggesting that aberrant c-Myc proteolysis may play a role in the pathogenesis of Burkitt's lymphoma. Finally, mutation of Thr-58, a major phosphorylation site in c-Myc and a mutational hot spot in Burkitt's lymphoma, increases c-Myc stability; however, mutation of c-Myc is not essential for stabilization in Burkitt's lymphoma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“1B, turnover of c-Myc was blocked in cells treated with either ALLN or with lactacystin, an inhibitor specific for the proteasome (21).”
BackgroundThe ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, C. G., Tamai, M., & Hanada, K. (1982) · Biochemical Journal · doi:10.1042/bj2010189 · Cited by 1,026
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 923
Marcu, K. B., Bossone, S. A., & Patel, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.004113 · Cited by 802
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Harrington, E. A., Bennett, M. R., Fanidi, A., & Evan, G. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06630.x · Cited by 742
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
Control of c-myc Regulation in Normal and Neoplastic Cells
(1991) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60476-5 · Cited by 618
The MYC protein activates transcription of the alpha-prothymosin gene.
Eilers, M., Schirm, S., & Bishop, J. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07929.x · Cited by 578
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., & Ballard, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11259 · Cited by 554
Varshavsky, A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01122-5 · Cited by 545
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann, S. R., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 495
Self-citationThe Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., & Lee, W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1697 · Cited by 447
Salghetti, S. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 443
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 443
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
Facchini, L. M., & Penn, L. Z. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.633 · Cited by 377
Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells
Taub, R., Moulding, C., Battey, J., Murphy, W., Vasicek, T., Lenoir, G. M., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90227-7 · Cited by 331
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation
Cole, M. D., & McMahon, S. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202748 · Cited by 314
Hann, S. R., Abrams, H. D., Rohrschneider, L. R., & Eisenman, R. N. (1983) · Cell · doi:10.1016/0092-8674(83)90535-4 · Cited by 290
Self-citationBhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., & Magrath, I. (1993) · Nature Genetics · doi:10.1038/ng0993-56 · Cited by 285
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma
Rabbitts, T. H., Hamlyn, P. H., & Baer, R. (1983) · Nature · doi:10.1038/306760a0 · Cited by 281
Myc oncoproteins are phosphorylated by casein kinase II.
Lüscher, B., Kuenzel, E. A., Krebs, E. G., & Eisenman, R. N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03481.x · Cited by 279
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228
The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.
Hofmann, F., Martelli, F., Livingston, D. M., & Wang, Z. (1996) · Genes & Development · doi:10.1101/gad.10.23.2949 · Cited by 227
Lutterbach, B., & Hann, S. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220
Self-citationHateboer, G., Kerkhoven, R. M., Shvarts, A., Bernards, R., & Beijersbergen, R. L. (1996) · Genes & Development · doi:10.1101/gad.10.23.2960 · Cited by 208
Campanero, M. R., & Flemington, E. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2221 · Cited by 199
Lin, R., Beauparlant, P., Makris, C., Meloche, S., & Hiscott, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1401 · Cited by 199
The protein encoded by the human proto-oncogene c-myc.
Ramsay, G., Evan, G. I., & Bishop, J. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7742 · Cited by 194
Mcelhinny, J. A., Trushin, S. A., Bren, G. D., Chester, N., & Paya, C. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.899 · Cited by 187
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
Stancovski, I., Gonen, H., Orian, A., Schwartz, A. L., & Ciechanover, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7106 · Cited by 169
Schwarz, E. M., Van Antwerp, D., & Verma, I. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3554 · Cited by 163
Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson, M., Bakardjiev, A. I., Klein, G., & Lüscher, B. (1993) · PubMed · Cited by 162
c-myc protein expression in untransformed fibroblasts.
Waters, C. M., Littlewood, T. D., Hancock, D. C., Moore, J. P., & Evan, G. I. (1991) · PubMed · Cited by 160
c-myc and c-myb Protein Degradation: Effect of Metabolic Inhibitors and Heat Shock
Lüscher, B., & Eisenman, R. N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2504 · Cited by 158
Hann, S., Dixit, M., Sears, R. C., & Sealy, L. J. (1994) · Genes & Development · doi:10.1101/gad.8.20.2441 · Cited by 146
Self-citationHoang, A. T., Lutterbach, B. A., Lewis, B. C., Yano, T., Chou, T., Barrett, J. F., Raffeld, M. A., Hann, S., & Dang, C. V. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4031 · Cited by 139
Self-citationDegradation of c-Fos by the 26S Proteasome Is Accelerated by c-Jun and Multiple Protein Kinases
Tsurumi, C., Ishida, N., Tamura, T., Kakizuka, A., Nishida, E., Okumura, E., Kishimoto, T., Inagaki, M., Okazaki, K., Sagata, N., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5682 · Cited by 139
Spotts, G. D., Patel, S. V., Xiao, Q., & Hann, S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1459 · Cited by 133
Self-citationFlinn, E. M., Busch, C. M. C., & Wright, A. P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5961 · Cited by 131
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 128
Self-citationEpstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ruf, I. K., Rhyne, P., Yang, H. J., Borza, C. M., Hutt‐Fletcher, L. M., Cleveland, J. L., & Sample, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1651 · Cited by 127
Salama, S. R., Hendricks, K. B., & Thorner, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7953 · Cited by 120
Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosisPreprint
Xiao, Q., Claassen, G. F., Shi, J., Adachi, S., Sedivy, J. M., & Hann, S. (1998) · Genes & Development · doi:10.1101/gad.12.24.3803 · Cited by 119
Self-citationThe role of protein stability in the cell cycle and cancer
Elledge, S. J., & Harper, J. W. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00005-5 · Cited by 117
Activation of a translocated c-myc gene: role of structural alterations in the upstream region.
Wiman, K. G., Clarkson, B., Hayday, A., Saito, H., Tonegawa, S., & Hayward, W. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6798 · Cited by 112
Showe, L. C., Ballantine, M., Nishikura, K., Erikson, J., Kaji, H., & Croce, C. M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.501 · Cited by 108
Developing selective inhibitors of calpain
Wang, K. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90060-l · Cited by 107
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., & Raffeld, M. A. (1993) · PubMed · Cited by 101
Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb.
Lüscher, B., & Eisenman, R. N. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.4.775 · Cited by 90
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn, S. L., Salwen, H. R., Quasney, M. W., Ikegaki, N., Cowan, J. M., Herst, C. V., Kennett, R. H., Rosen, S. T., DiGiuseppe, J. A., & Brodeur, G. M. (1990) · PubMed · Cited by 88
Expression of the c-myc Proto-Oncogene during Development of Xenopus laevis
King, M. W., Roberts, J. M., & Eisenman, R. N. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4499-4508.1986 · Cited by 86
Spotts, G. D., & Hann, S. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.3952 · Cited by 81
Self-citationLiu, Z.-P., Galindo, R. L., & Wasserman, S. A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3413 · Cited by 77
Bies, J., & Wolff, L. (1997) · Oncogene · doi:10.1038/sj.onc.1200828 · Cited by 76
Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
Clark, H. M., Yano, T., Otsuki, T., Jaffe, E. S., Shibata, D., & Raffeld, M. A. (1994) · PubMed · Cited by 73
Albert, T., Urlbauer, B., Kohlhuber, F., Hammersen, B., & Eick, D. (1994) · PubMed · Cited by 66
The Signal Response of IκBα Is Regulated by Transferable N- and C-Terminal Domains
Brown, K., Franzoso, G., Baldi, L., Carlson, L. M., Mills, L., Lin, Y. C., Gerstberger, S. M., & Siebenlist, U. K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3021 · Cited by 52
Stabilization of c-myc protein in human glioma cells
Shindo, H., Tani, E., Matsumuto, T., Hashimoto, T., & Furuyama, J.-I. (1993) · Acta Neuropathologica · doi:10.1007/bf00369446 · Cited by 34
Ubiquitin in signal transduction and cell transformation
Isaksson, A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00011-x · Cited by 24
Axelson, H., Arsenian‐Henriksson, M., Wang, Y., Magnusson, K. P., & Klein, G. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00449-1 · Cited by 18
Ce, A., Magnusson, K. P., Sp, P., Andersson, K., Klein, G., Colé, & Wiman, K. G. (1995) · PubMed · Cited by 16
Cited by
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
Balasubramanian, S., Hurley, L. H., & Neidle, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3428 · Cited by 1,692
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. H. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,143
Metadata
- Authors
- Gregory, M. A., & Hann, S. R.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-04
- Volume
- 20
- Issue
- 7
- Pages
- 2423-2435
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2164461769
- Cited by
- 469
- References
- 73
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.